國際會議
|
- Wang HY, Yang FC, Yang CF, Tsai CK, KO PS, Liu YC, Chen NJ. Ratio of Circulating CD8+ T Lymphocytes to M-MDSCs (CD8MMR): A Novel Prognostic Predictor for Treatment-Naive DLBCL Patients. Blood. Dec 2023;142(Supplement 1):1763 (2023年美國血液病年會: 瀰漫性大B細胞淋巴瘤)
- Wang HY, Yang FC, Liu YC, KO PS, Yang CF, Chen NJ. Higher expression of TREM-2 on M-MDSC cell surface independently predicts worse survival in adults with newly diagnosed and treatment-naïve non-Hodgkin lymphoma. Blood. Dec 2021;138(Supplement 1):1446. (2021年美國血液病年會: 淋巴瘤)
- Wang HY, Yang CF, Lin CH, Hsiao LT, Ko PS, Liu YC, Hung YC, Chiou TJ, Chen PM, Gau JP, Liu JH, Liu CJ. Real-World Data on frontline intensification providing survival benefits in patients with higher-risk Primary CNS Lymphoma. (2020年歐洲血液病年會: 原發性腦部淋巴瘤)
|
代表著作
|
- Wang HY, Yang FC, Yang CF, Liu YC, Ko PS, Li CJ, Tsai CK, Chung YL, Chen NJ. Surface TREM2 on circulating M-MDSCs as a novel prognostic factor for adults with treatment-naïve DLBCL. Experimental Hematology & Oncology. 2023;12(1):35 (瀰漫性大B細胞淋巴瘤; IF=11.4)
- Wang HY, Yang CF, Lin CH, Hsiao LT, Ko PS, Liu YC, Chiou TJ, Chen PM, Gau JP, Liu JH, Liu CJ. Long-term outcomes of frontline intensification in primary CNS lymphoma: A real-world single-center experience. Cancer Medicine. 2023;12(7):8089-8101. (原發性腦部淋巴瘤)
- Wang HY, Yang CF, Chiou TJ, Gau JP, Chen PM, Tsai CY, Hsu HC, Wang FD, Liu JH, Hsiao LT. Primary bone marrow lymphoma: a hematological emergency in adults with fever of unknown origin. Cancer Medicine. Jul 2018;7(8):3713-3721. (原發性骨髓淋巴瘤)
- Wang HY, Yang CF, Chiou TJ, Yang SH, Gau JP, Yu YB, Chen PM, Hsu HC, Fung CP, Lin HY, Tzeng CH, Liu JH, Hsiao LT. Risk of hemophagocytic lymphohistiocytosis in adults with fevers of unknown origin: the clinical utility of a new scoring system on early detection. Hematological oncology. Dec 2017;35(4):835-844. (噬血性症候群)
|